Showing results (61-70 of 637) with videos related to
Sort By:
Pageof 64
Current Pharmaceutical Design|June 19, 2001
Statins and bone formationI R Garrett, G Gutierrez, G R MundyLancet (London, England)|June 21, 1980
Primary hyperparathyroidism: changes in the pattern of clinical presentationG R Mundy, D H Cove, R FiskenEndocrinology|May 1, 1991
Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude miceK Black, I R Garrett, G R MundyThe Journal of Laboratory and Clinical Medicine|November 1, 1978
Effects of glucocorticoids on osteoclast-activating factorM Strumpf, M A Kowalski, G R MundyEndocrinology|November 1, 1989
Bolus injections of recombinant human interleukin-1 cause transient hypocalcemia in normal miceB F Boyce, A J Yates, G R MundyJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1986
Alterations in hormone-sensitive adenylate cyclase of cloned rat osteosarcoma cells during long-term cultureG E Gutierrez, G R Mundy, M S KatzThe Journal of Clinical Investigation|September 1, 1984
Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancyS M D'Souza, K J Ibbotson, G R MundyEndocrinology|December 1, 1984
Adenylate cyclase of osteoblast-like cells from rat osteosarcoma is stimulated by calcitonin as well as parathyroid hormoneG E Gutierrez, G R Mundy, M S KatzJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1987
Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorptionB M Thomson, G R Mundy, T J ChambersThe Journal of Laboratory and Clinical Medicine|June 1, 1975
Release of osteoclast activating factor by normal human peripheral blood leukocytesC L Trummel, G R Mundy, L G RaiszPageof 64